IL326153A - צורות מצב מוצק של gusacitinib - Google Patents
צורות מצב מוצק של gusacitinibInfo
- Publication number
- IL326153A IL326153A IL326153A IL32615326A IL326153A IL 326153 A IL326153 A IL 326153A IL 326153 A IL326153 A IL 326153A IL 32615326 A IL32615326 A IL 32615326A IL 326153 A IL326153 A IL 326153A
- Authority
- IL
- Israel
- Prior art keywords
- gusacitinib
- solid state
- state forms
- forms
- solid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363515864P | 2023-07-27 | 2023-07-27 | |
| PCT/US2024/039746 WO2025024765A1 (en) | 2023-07-27 | 2024-07-26 | Solid state forms of gusacitinib |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL326153A true IL326153A (he) | 2026-03-01 |
Family
ID=92538749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL326153A IL326153A (he) | 2023-07-27 | 2024-07-26 | צורות מצב מוצק של gusacitinib |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4750775A1 (he) |
| KR (1) | KR20260078905A (he) |
| CN (1) | CN122206677A (he) |
| AU (1) | AU2024299978A1 (he) |
| IL (1) | IL326153A (he) |
| TW (1) | TW202510870A (he) |
| WO (1) | WO2025024765A1 (he) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112014003981A2 (pt) | 2011-08-23 | 2017-03-07 | Endo Pharmaceuticals Inc | compostos de pirimido-piridazinona e seu uso |
| CN110809471A (zh) | 2017-04-28 | 2020-02-18 | 阿沙纳生物科学公司 | 治疗特应性皮炎以及提高活性药物成分稳定性的制剂、方法、试剂盒和剂型 |
| US20250171448A1 (en) * | 2022-02-23 | 2025-05-29 | Teva Pharmaceuticals International Gmbh | Solid state forms of gusacitinib |
-
2024
- 2024-07-26 IL IL326153A patent/IL326153A/he unknown
- 2024-07-26 AU AU2024299978A patent/AU2024299978A1/en active Pending
- 2024-07-26 TW TW113127869A patent/TW202510870A/zh unknown
- 2024-07-26 EP EP24761345.8A patent/EP4750775A1/en active Pending
- 2024-07-26 KR KR1020267006191A patent/KR20260078905A/ko active Pending
- 2024-07-26 CN CN202480059997.XA patent/CN122206677A/zh active Pending
- 2024-07-26 WO PCT/US2024/039746 patent/WO2025024765A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2024299978A1 (en) | 2026-03-12 |
| WO2025024765A1 (en) | 2025-01-30 |
| KR20260078905A (ko) | 2026-05-29 |
| CN122206677A (zh) | 2026-06-12 |
| TW202510870A (zh) | 2025-03-16 |
| EP4750775A1 (en) | 2026-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA215228S (en) | Set of earbuds | |
| EP4165031A4 (en) | SOLID FORMS OF CYANTRANILIPROL | |
| CA221468S (en) | Part of earphone | |
| KR102423280B9 (ko) | Sot-mram 면적 최적화 기법 | |
| GB202103774D0 (en) | Detectiion of Ransomware | |
| GB202411655D0 (en) | Application of circHIF1a | |
| IL317645A (he) | שיטות להכנת טולברוטיניב | |
| GB202011709D0 (en) | Solid dispersion of opicapone | |
| IL304159A (he) | תכשיר המכיל bl-8040 | |
| IL318553A (he) | וריאנטים של tdp-43 עמידים לצבירה | |
| GB202115776D0 (en) | Design of engineering components | |
| IL326152A (he) | צורות מצב מוצק של gusacitinib | |
| IL321161A (he) | צורות מוצקות של תרכובות נפתירידין | |
| GB2612588B (en) | Design of engineering components | |
| IL319179A (he) | צורות מוצקות של דניפנסטאט | |
| CA3303749A1 (en) | Solid state forms of samuraciclib | |
| CA3299931A1 (en) | Solid state forms of gusacitinib | |
| CA3299990A1 (en) | Solid state forms of gusacitinib | |
| CA3297108A1 (en) | Solid state forms of sunvozertinib | |
| CA3294911A1 (en) | Solid state forms of rencofilstat | |
| CA3268966A1 (en) | Solid state forms of denifanstat | |
| GB202508287D0 (en) | Co-amorphous solid forms of flavonoids | |
| GB202215264D0 (en) | Use of urolithins | |
| CA234591S (en) | Part of windlass | |
| GB202301974D0 (en) | The capability of becoming telepathic |